home > research channels > sectors > pharma


Latest News
28-Jun-2017 Fortis' Diagnostic Arm SRL Set for Demerger This Month-end
27-Jun-2017 Cadila Board Approves Plan to Raise Up to Rs 18,500 crore
27-Jun-2017 Lupin Founder DB Gupta: A Hero of Indian Pharma and A Teacher to Many
31-Mar-2017 Indian Cos Vie for Novartis' Respiratory Brands
  more...
Latest Reports
Aug-17 New pharma policy on the anvil - Edelweiss Securities  
Jul-17 GST impact, US price erosion to weigh on Q1 - ICICI direct.com  
Jul-17 Indian Pharmaceuticals Industry - CARE Research  
Jul-17 India Pharma: Q1 preview - Anand Rathi  
  more...

Quarterly Summary (June Quarter)
Desc Current Previous Per.Chg
Sales 18903.5 21616.8 -12.6
Otherincome 720.8 981.8 -26.6
Expense 16139.5 16141.3 0.0
RawMaterial 6151.5 6099.3 0.9
StaffCost 3256.6 3007.6 8.3
ExciseDuty 134.8 20.3 562.7
OtherExp 5512.6 5198.1 6.0
Interest 495.4 584.5 -15.2
GrossProfit 3256.7 6416.8 -49.2
Depreciation 882.9 796.0 10.9
Tax 628.9 1317.4 -52.3
NetProfit 1713.2 4317.1 -60.3
Total.Comp 60 -- --
Source: ETIG Database

Sectoral Companies As on 17 Aug 2017
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 117229.80
Cadila Healt 49321.87
Piramal Entp 46912.89
Cipla 46134.61
Lupin 43101.47
Aurobindo Ph 41218.07
Dr.Reddy's 33329.82
Torrent Phar 22064.60
Alkem Labora 21752.12
GlaxoSmith.P 20201.37
Biocon 19755.00
Glenmark Pha 17497.81
Divi's Lab 17134.80
  click here for the complete list